Martin Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-36,193
Closed -$4.11M 68
2024
Q3
$4.11M Sell
36,193
-11,853
-25% -$1.41M 2.03% 24
2024
Q2
$5.95M Sell
48,046
-17,378
-27% -$2.24M 2.4% 19
2024
Q1
$8.63M Sell
65,424
-1,628
-2% -$201K 3.31% 1
2023
Q4
$7.31M Sell
67,052
-735
-1% -$76.3K 2.98% 7
2023
Q3
$6.98M Buy
67,787
+32
+0% +$3.45K 2.94% 7
2023
Q2
$7.82M Sell
67,755
-1,501
-2% -$170K 3.17% 3
2023
Q1
$7.37M Buy
69,256
+736
+1% +$79.5K 3.06% 4
2022
Q4
$7.6M Buy
68,520
+1,135
+2% +$116K 3.14% 4
2022
Q3
$5.8M Buy
67,385
+2,361
+4% +$211K 2.69% 9
2022
Q2
$5.93M Buy
65,024
+1,595
+3% +$141K 2.81% 8
2022
Q1
$5.2M Buy
63,429
+5,514
+10% +$435K 2.38% 23
2021
Q4
$4.44M Sell
57,915
-2,017
-3% -$161K 2.1% 24
2021
Q3
$4.5M Buy
59,932
+679
+1% +$51.6K 2.27% 24
2021
Q2
$4.61M Sell
59,253
-2,127
-3% -$158K 2.34% 22
2021
Q1
$4.51M Buy
61,380
+22,584
+58% +$1.67M 2.4% 19
2020
Q4
$3.03M Buy
38,796
+159
+0.4% +$12.2K 1.77% 29
2020
Q3
$3.06M Sell
38,637
-540
-1% -$42.3K 2.05% 27
2020
Q2
$2.89M Sell
39,177
-208
-0.5% -$15.7K 2.03% 25
2020
Q1
$2.89M Buy
39,385
+9,827
+33% +$772K 2.2% 23
2019
Q4
$2.56M Buy
+29,558
New +$2.43M 1.52% 33

Other funds holding MRK

Martin Capital Partners's MRK Position: Q4 2024 in Review

Martin Capital Partners sold out of Merck (MRK) in Q4 2024, closing a stake of 36,193 shares — an estimated $4.11M sold.

Martin Capital Partners first reported a position in MRK in Q4 2019 and held it in 20 quarters. The position peaked at $8.63M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Martin Capital Partners reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Martin Capital Partners sold 36,193 Merck shares in Q4 2024, an estimated $4.11M.
  • Martin Capital Partners first reported a position in Merck in Q4 2019 and held it in 20 quarters.
  • Martin Capital Partners's Merck position peaked at $8.63M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Martin Capital Partners's 13F filing for Q4 2024, filed 27 Jan 2025.